elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37520379-E121A505-92C4-4BE6-8CB1-462322168F4A
Q37520379-E121A505-92C4-4BE6-8CB1-462322168F4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37520379-E121A505-92C4-4BE6-8CB1-462322168F4A
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.
P2860
Q37520379-E121A505-92C4-4BE6-8CB1-462322168F4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37520379-E121A505-92C4-4BE6-8CB1-462322168F4A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15c27121e805e802053f5e8174dd35b6d6f687d8
P2860
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.